We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Red Rock Resorts
RRR
$3.62B
| $264K | ﹤0.01% |
13,001
-27,947
| -68% | -$657K |
|
2002
Novavax
NVAX
$1.31B
| $263K | ﹤0.01% |
7,157
+1,969
| +38% | +$76.3K |
|
2003
Axcelis
ACLS
$4.33B
| $262K | ﹤0.01% |
14,735
-55,917
| -79% | -$994K |
|
2004
Viking Therapeutics
VKTX
$4B
| $261K | ﹤0.01% |
34,156
-26,778
| -44% | -$320K |
|
|
XOG
2005
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $261K | ﹤0.01% |
+60,770
| New | +$452K |
|
|
CALA
2006
DELISTED
Calithera Biosciences, Inc
CALA
| $260K | ﹤0.01% |
3,243
-523
| -14% | -$51.6K |
|
2007
Astronics
ATRO
$3.84B
| $259K | ﹤0.01% |
+10,204
| New | +$269K |
|
2008
Helix Energy Solutions
HLX
$1.41B
| $259K | ﹤0.01% |
47,933
-52,278
| -52% | -$426K |
|
|
GHL
2009
DELISTED
Greenhill & Co., Inc.
GHL
| $259K | ﹤0.01% |
+10,599
| New | +$259K |
|
|
MFA
2010
MFA Financial
MFA
$933M
| $257K | ﹤0.01% |
9,613
-12,731
| -57% | -$358K |
|
|
NSA
2011
DELISTED
National Storage Affiliates Trust
NSA
| $257K | ﹤0.01% |
9,723
-376
| -4% | -$10.1K |
|
|
ACH
2012
DELISTED
Alum Corp of China Ltd
ACH
| $257K | ﹤0.01% |
32,835
+2,757
| +9% | +$25.9K |
|
|
BOLD
2013
DELISTED
Audentes Therapeutics, Inc
BOLD
| $257K | ﹤0.01% |
12,046
-13,637
| -53% | -$352K |
|
|
ALDR
2014
DELISTED
Alder Biopharmaceuticals
ALDR
| $257K | ﹤0.01% |
25,097
+4,304
| +21% | +$55.1K |
|
2015
Horizon Bancorp
HBNC
$1.04B
| $255K | ﹤0.01% |
16,145
-24,421
| -60% | -$418K |
|
|
TBRG
2016
DELISTED
TruBridge
TBRG
| $255K | ﹤0.01% |
+10,160
| New | +$265K |
|
2017
Tyler Technologies
TYL
$12.8B
| $254K | ﹤0.01% |
1,368
+160
| +13% | +$31.6K |
|
2018
American Coastal Insurance
ACIC
$493M
| $252K | ﹤0.01% |
15,144
+3,803
| +34% | +$72.4K |
|
2019
Badger Meter
BMI
$4.03B
| $252K | ﹤0.01% |
5,118
-2,836
| -36% | -$145K |
|
2020
Ardelyx
ARDX
$997M
| $251K | ﹤0.01% |
140,030
+52,633
| +60% | +$155K |
|
|
GWR
2021
DELISTED
Genesee & Wyoming Inc.
GWR
| $251K | ﹤0.01% |
+3,397
| New | +$272K |
|
|
ASXC
2022
DELISTED
Asensus Surgical, Inc.
ASXC
| $250K | ﹤0.01% |
8,520
-4,725
| -36% | -$215K |
|
2023
Agios Pharmaceuticals
AGIO
$1.93B
| $249K | ﹤0.01% |
5,392
-7,017
| -57% | -$433K |
|
|
HOME
2024
DELISTED
At Home Group Inc.
HOME
| $249K | ﹤0.01% |
13,344
-13,668
| -51% | -$348K |
|
|
BMS
2025
DELISTED
Bemis
BMS
| $247K | ﹤0.01% |
5,383
-11,899
| -69% | -$555K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.